Teva Ascends On Allergan Generics Purchase, Mylan NV (MYL) Withdrawal

Page 2 of 2

How are hedge funds trading Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)?

Of the funds tracked by Insider Monkey, Point State Capital, managed by Zach Schreiber, holds the largest position in Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) as of March 31, which is valued at $642.3 million and contains 10.31 million shares, comprising 8.7% of its 13F portfolio. On Point State Capital’s heels is Israel Englander of Millennium Management, with a $560.1 million position held in 8.99 million shares. Some other members of the smart money that hold long positions include Jonathon Jacobson’s Highfields Capital Management, Robert Pohly’s Samlyn Capital and David E. Shaw’s D.E. Shaw & Co., L.P.

Hoplite Capital Management, led by John Lykouretzos, initiated the largest stake in Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) in the first quarter. Hoplite Capital Management held 1.34 million shares, worth $83.70 million at the end of March, while Jeremy Green’s Redmile Group acquired around 854,000 shares during the same period. However, Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital and George Soros’ Soros Fund Management unloaded around 6.85 million shares and 4.86 million shares.

As hedge funds were bullish on Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) in the first quarter, we also recommend being long in the stock at the moment.

Disclosure: None

Page 2 of 2